
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Ipsen (France), France, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
42%
Total
Publications
1.9K
Total Open
Publications
799
Total
Citations
40K
Open Access
Percentage
42%
Total
Publications
1.9K
Total Open
Publications
799
Total
Citations
40K
Breakdown
Publisher Open
15%
Both
22%
Other Platform Open
4%
Closed
59%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 37%
265
Hybrid 41%
289
No Guarantees 22%
158
Other Platform Open
Domain 71%
363
Institution 37%
186
Other Internet 20%
100
Public 4%
18
Preprint 3%
15
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 364 |
DOI | Other Internet | 89 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 41 |
Europe PMC | Domain | 40 |
Royal Netherlands Academy of Arts and Sciences | Institution | 19 |
King's College London | Institution | 17 |
Unknown Repository | Other Internet | 15 |
Harris County Public Library | Institution | 15 |
Figshare | Public | 15 |
University College of Arts Crafts and Design | Institution | 12 |